


To provide an above-average and growing income without sacrificing the benefits of long-term capital growth by investing primarily in the UK.
| Name | % Net Assets |
|---|---|
| Vodafone Group PLC | 5.5% |
| Morgan Stanley Euro Conv Bond | 5.3% |
| BP PLC | 4.4% |
| Royal Dutch Shell | 4.3% |
| AstraZeneca Plc | 3.9% |
| GlaxoSmithKline PLC | 3.4% |
| Germany (FED REP) 4.25% BDS 07/04/20 | 3.3% |
| BHP Billiton | 3.2% |
| UK Conv Gilt 4.75% 09/07/2015 | 2.7% |
| HSBC Holdings PLC | 2.4% |
| Key | % Net Assets |
|---|---|
| 5.5% | |
| 5.3% | |
| 4.4% | |
| 4.3% | |
| 80.5% |
| Date | 06-Apr-2020 |
|---|---|
| Bid | 405.20p |
| Offer | 425.50p |
| Currency | GBP |
| Change | -0.30p |
| % | -0.07% |
| YTD change | 415.35p |
| YTD % | n/a |
| Fund Inception | 12/08/1994 |
|---|---|
| Fund Manager | Philip Brides |
| TER | 0.02 (27-Jun-2014) |
| Minimum Investment | |
|---|---|
| Initial | £500 |
| Additional | n/a |
| Savings | £50 |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.09 |
You are here: research